Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice
Authors:
- Se-Eun JangSJSe-Eun Jang
- Jin-Ju JeongJJJin-Ju Jeong
- Eun-Ha JohEJEun-Ha Joh
- Myung Joo HanMHMyung Joo Han
- Dong-Hyun KimDKDong-Hyun Kim
- 1 February 2013
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 15 (2) , 433-441
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education and Human Resources Development
This publication has 25 references indexed in Scilit:
- A High-Fat Diet Is Associated With Endotoxemia That Originates From the GutGastroenterology, 2012
- The Active Human Gut Microbiota Differs from the Total MicrobiotaPLOS ONE, 2011
- Epidemiology of IBD during the twentieth century: an integrated viewBest Practice & Research Clinical Gastroenterology, 2004
- Crohn's diseaseThe Lancet, 2002
- Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel DiseaseInfection and Immunity, 2000
- Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivoNature Medicine, 2000
- Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal TransductionJournal of Biological Chemistry, 1999
- Changes in Bacterial Enzymes and PCR Profiles of Fecal Bacteria from a Patient with Ulcerative Colitis Before and After Antimicrobial TreatmentsDigestive Diseases and Sciences, 1999
- A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.Journal of Clinical Investigation, 1995
- Interleukin 1β Is Expressed Predominantly by Enterocytes in Experimental ColitisGastroenterology, 1991